ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 129 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $311,000 | -25.4% | 170,779 | +8.1% | 0.01% | -39.1% |
| Q2 2021 | $417,000 | -18.4% | 158,011 | +11.4% | 0.02% | -23.3% |
| Q1 2021 | $511,000 | +120.3% | 141,889 | +54.0% | 0.03% | +87.5% |
| Q4 2020 | $232,000 | +182.9% | 92,158 | +499.9% | 0.02% | -54.3% |
| Q4 2016 | $82,000 | – | 15,362 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $49,697,000 | 12.67% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 9,642,760 | $31,628,000 | 5.74% |
| MILLER VALUE PARTNERS, LLC | 12,619,730 | $41,393,000 | 1.84% |
| MAGNOLIA CAPITAL ADVISORS LLC | 90,585 | $297,000 | 0.38% |
| Sargent Investment Group, LLC | 232,025 | $759,000 | 0.28% |
| Old West Investment Management, LLC | 210,583 | $690,000 | 0.20% |
| Virtus ETF Advisers LLC | 112,619 | $369,000 | 0.18% |
| tru Independence LLC | 213,712 | $701,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 180,297 | $591,000 | 0.08% |
| Golden State Wealth Management, LLC | 90,585 | $297,000 | 0.08% |